Gene Clouse

TrialStat Corp. provides clinical data solutions for life science products. It offers customer suport, CROFirst, user training and data center services. The firm serves pharmaceutical, biotechnology and contract research organizations. The company was founded by Peter O'Blenis in 2001 and is headquartered in Ottawa, Canada.

Xbio Systems provides integrated software solutions for the global Life Sciences sector. Their solutions have been designed to reduce business risk, improve governance and regulatory compliance, increase user acceptance, maximize operational control and reduce the cost of IT. At the center of each solution is the Xbio platform that automates workflows and provides advanced content management within a secure, web-based environment. By combining these two basic building blocks, Xbio's clients are able to make significant and material differences to cycle times and operational costs, with clients regularly reporting productivity improvements in excess of 40%. The platform also helps clients to avoid the high sunk costs typically associated with Life Sciences IT solutions. Customers have the option of deploying the software internally or entering into a managed services arrangement. Software modules can also be purchased or subscribed to as and when they are required and turned off to reduce costs when development changes. The open architecture of the platform allows for ready integration with existing IT solutions. During deployment, the workflows, templates, access rights and toolsets can be designed and configured to support customer business processes and subsequently maintained in-house across all related activities in the drug development lifecycle.

Part of Xerox Holdings Corp., Xerox AB is a Swedish company.

ClearTrial provides Clinical Trial Operations (CTO) software that makes the planning, forecasting, and tracking of clinical project and financial performance faster and more accurate. The ClearTrial system creates dramatic internal and supplier efficiencies and cost savings for their biopharmaceutical and medical device customers by integrating their clinical operations from Plan to Payment™. Top 20 biopharmaceutical companies, medical device companies, and small biotechs in the US, Europe, and Japan have all embraced their software. These organizations have come to rely on ClearTrial's industry intelligence, embedded clinical knowledge, and activity-based planning approach to add speed, flexibility, accuracy, and consistency to clinical development.